Connect Biopharma Holdings Ltd (CNTB)
1.79
+0.22
(+14.38%)
USD |
NASDAQ |
May 31, 16:00
1.76
-0.03
(-1.68%)
After-Hours: 20:00
Connect Biopharma Holdings Total Liabilities (Quarterly): 24.85M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 24.85M |
| June 30, 2023 | 15.35M |
| June 30, 2023 | 15.35M |
| December 31, 2022 | 16.52M |
| June 30, 2022 | 21.73M |
| Date | Value |
|---|---|
| June 30, 2022 | 21.73M |
| December 31, 2021 | 18.80M |
| June 30, 2021 | 14.09M |
| June 30, 2021 | 14.09M |
| December 31, 2020 | 322.93M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
14.09M
Minimum
Jun 2021
322.93M
Maximum
Dec 2020
48.55M
Average
17.66M
Median
Total Liabilities (Quarterly) Benchmarks
| Vanda Pharmaceuticals Inc | 108.69M |
| Mirum Pharmaceuticals Inc | 417.36M |
| 89bio Inc | 66.78M |
| Tharimmune Inc | 1.838M |
| Lipella Pharmaceuticals Inc | 0.5759M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 125.89M |
| Shareholders Equity (Quarterly) | 101.04M |